Results 111 to 120 of about 6,803 (205)

Alport's Syndrome

Ear, Nose & Throat Journal, 1992
S P, Andreoli, M, Deaton
openaire   +2 more sources

The heterozygous mutation COL4A4 c.817-1G>A causes Alport syndrome in a Chinese family: a case report

Frontiers in Pediatrics
BackgroundAlport syndrome is an inherited glomerular disease that leads to progressive kidney failure, hearing loss, and eye problems. Diagnosis mostly relies on tests of tissue pathology and genetic analysis.
Dayan Wang, Dayan Wang, Xiaobing Li, Xiaobing Li, Kaichao Cheng, Kaichao Cheng, Lanjin Zheng, Lanjin Zheng, Pengfei Yu, Pengfei Yu, Panjian Lai, Panjian Lai   +11 more
doaj   +1 more source

Alport syndrome

Kidney International, 1996
Kashtan, Clifford E., Michael, Alfred F.
openaire   +2 more sources

Autosomal Dominant Alport′s syndrome: Study of a Large Tunisian Family

Saudi Journal of Kidney Diseases and Transplantation, 2006
Alport′s syndrome is a hereditary nephritis that may lead to end-stage renal disease (ESRD) in early adult life. It is a clinically and genetically heterogeneous nephropathy. Alport′s syndrome is often associated with sensorineural deafness
Kharrat M, Makni S, Makni K, Kammoun K, Charfeddine K, Azaeiz H, Jarraya F, Hmida M, Gubler M, Ayadi H, Hachicha J   +10 more
doaj  

Alport's syndrome.

Ear, nose, & throat journal, 1990
We review Alport's syndrome based on the description of seven members of a family whose disease was confirmed by percutaneous biopsy of renal specimens. The importance of genetic counseling and of the prophylaxis of hearing losses through cochlear protection is emphasized.
D, Catandi M di, J A, de Oliveira, R S, Costa   +2 more
openaire   +1 more source

Hearing loss and truncating variants in Alport syndrome. [PDF]

Kidney Res Clin Pract
Yim HE.
europepmc   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights. [PDF]

Kidney360
Miyata KN, Miner JH.
europepmc   +1 more source

Systematic Review of IgA Nephropathy Coexisting With Alport Syndrome. [PDF]

Kidney Int Rep
Ying D, Zhang Y, Ma Y, Wei C, Fan J, Shi P, Wang M, Zhang J.   +7 more
europepmc   +1 more source

Sodium-Glucose Cotransporter-2-inhibitors in Adult Patients With Alport Syndrome. [PDF]

Kidney Int Rep
Toso D, Cinquina V, Econimo L, Cortinovis R, Zeni L, Tornambè V, Dordoni C, Ritelli M, Savoldi G, Mazza C, Scolari F, Alberici F, Izzi C.   +12 more
europepmc   +1 more source

SPARC upregulation mediates podocyte injury in Alport syndrome mice. [PDF]

BMC Nephrol
Chi D, Chu H, Nie J, Zhang Y, Wang F, Ding J.   +5 more
europepmc   +1 more source